Work

POSTER: ABCL-1058: Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Clinical Activity of the Antibody-Drug Conjugate ARC-02 as Monotherapy and in Combination With Rituximab in Adults With B-Cell Non-Hodgkin's Lymphoma

Year: 2026

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(26)01135-3

Authors: Navid Hafez, Eliza Hawkes, Michael Gilbertson, Tara Cochrane, Katherine Lewis, Sara Soukup, Shinya Okamura, Qing Xu, Angela Hu, Bernd Schlereth, Vedran Radojcic, Don Stevens, Arvind Chaudry

Institutions: Austin Health, Olivia Newton-John Cancer Research Institute, Monash Health, Gold Coast Hospital, Sir Charles Gairdner Hospital, Linear Clinical Research, Taiho Oncology (United States), Araris Biotech AG (Switzerland), Norton Healthcare

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7204688664

FWCI:

Cites:

Cited by:

Related to: 10